Answers are grounded in this paper and cite their sources.
Background: Hyperpigmentation results from dysregulated melanogenesis, while existing tyrosinase inhibitors are limited by safety and stability concerns. Extracellular vesicles (EVs) from lactic acid bacteria are well-defined, cell-free nanoparticles, but their effects on melanogenesis remain poorly understood. We investigated whether EVs derived from Levilactobacillus brevis YD9-MRS-1 (YD9-EVs) attenuate α-MSH-induced melanogenic signaling upstream of microphthalmia-associated transcription factor (MITF) and associated cellular signaling. Methods: After characterization by nanoparticle tracking analysis, YD9-EVs were investigated in α-MSH-induced B16F10 cells to determine their effects on melanin synthesis, cellular tyrosinase activity, the expression of melanogenic regulators and enzymes (MITF, TYR, TRP-1, and TRP-2), and CREB-, PKA-, ERK-, and AKT-mediated signaling. Formulation tolerability was further evaluated using a human skin patch test. Results: YD9-EVs formed a homogeneous nanoparticle population, associated with B16F10 cells, and were non-cytotoxic within the tested range. In α-MSH-stimulated cells, YD9-EVs dose-dependently reduced melanin content and tyrosinase activity, with numerically greater effects than arbutin at the highest concentration. These effects were accompanied by decreased expression of MITF, TYR, TRP-1, and TRP-2, reduced CREB and ERK phosphorylation, increased AKT phosphorylation, and no consistent change in PKA phosphorylation. The formulation containing the highest active YD9-EV concentration caused no irritation in the human skin patch test. Conclusions: The anti-melanogenic activity of YD9-EVs was associated with downregulation of MITF, TYR, TRP-1, and TRP-2 and concurrent changes in CREB, ERK, and AKT signaling pathways. Although consistent suppression of PKA phosphorylation was not observed, the overall findings, together with the demonstrated short-term skin tolerability, support the further development of YD9-EVs as a cell-free candidate for hyperpigmentation control.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: